National and Kapodistrian University of Athens
Αξιολόγηση της συσχέτισης διαβητικής αμφιβληστροειδοπάθειας και καρδιαγγειακού κινδύνου σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
Abstract
dc:descriptionPurpose: To evaluate the potential association between diabetic retinopathy (DR), including diabetic macular edema (DME), and the atherosclerosis-related risk of cardiovascular events, as calculated using a specific tool. In addition, the potential association between DR and cardiovascular disease, as well as markers of endothelial function and arterial stiffness, was evaluated. Methods: Participants in this non-interventional, cross-sectional study included 215 patients of both sexes with type 2 diabetes (T2D). The demographic and clinical characteristics of the participants were recorded. All patients underwent a thorough ophthalmological examination and multimodal imaging. Systolic and diastolic blood pressure were also measured in all participants, and peripheral blood samples were collected for biochemical testing. Two separate analyses were performed: A. In 181 patients from the total sample who had no prior history of cardiovascular events, the “ASCVD 10-Year Risk Estimator Plus” tool was used to calculate the 10-year risk of a first atherosclerosis-related cardiovascular event. B. In 73 patients from the total sample, endothelial function was assessed by measuring the thickness of the endothelial glycocalyx, and arterial stiffness was assessed by measuring carotid-femoral pulse wave velocity (PWV), central aortic pressures, and the augmentation index (Aix). Results: A. The ASCVD score, as calculated using the “ASVCD Risk Estimator Plus” tool, was not found to be significantly associated with DR (p=0.191). Furthermore, the factors independently associated with DR were: duration of DM (p=0.002), HbA1c levels (p=0.006), and the presence of neuropathy (p=0.007). Male gender was found to be associated with DME (p=0.034).B. DR was significantly associated with a higher risk of cardiovascular disease (p=0.019). Similarly, patients with non-proliferative DR and proliferative DR were associated with significantly higher odds of cardiovascular disease compared to patients without DR (p=0.027). Furthermore, higher PWV was significantly associated with more severe DR (p=0.031), and a similar trend was observed for higher PWV and the presence of DR (p=0.071). Conclusions: DR is strongly associated with cardiovascular disease and can therefore be used as a clinical indicator of systemic vascular disease. The “ASCVD Risk Estimator Plus” cardiovascular risk assessment tool does not appear to be reliable in patients with T2D. Since the diagnosis of DR in patients with T2D is associated with an increased risk of cardiovascular disease, a thorough cardiac evaluation should not be omitted, and the importance of close monitoring for the early detection of macro- and microvascular complications, as well as for timely intervention, should be emphasized.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agapitou, Chrysa
- Αγαπητού, Χρύσα
Subjects
dc:subject × 16- Διαβητική αμφιβληστροειδοπάθεια
- Καρδιαγγειακός κίνδυνος
- Σακχαρώδης διαβήτης τύπου 2
- Ενδοθηλιακός γλυκοκάλυκας
- Αρτηριακή σκληρία
- Diabetic retinopathy
- Cardiovascular risk
- Type 2 diabetes mellitus
- Endothelial glycocalyx
- Arterial stiffness
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Οφθαλμολογία
- Clinical Medicine
- Medical and Health Sciences
- Ophthalmology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62433